In Brief: FDA reform update
This article was originally published in The Gray Sheet
FDA reform update: House Republican FDA reform package has 159 cosponsors from "Republicans and Democrats across the political spectrum," Rep. Jim Greenwood (R-Penn.), the floor manager for the package, says in a special order on the House floor May 29. The Commerce Committee plans to release an amended version of the reform package one week prior to mark-up, which is slated to begin in mid-June...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.